By Sheri Kasprzak
New York, May 1 - Dobi Medical International, Inc. said it completed a private placement of discounted secured convertible debentures. The company issued $6 million in debentures and received $5.25 million in proceeds.
The zero-coupon debentures due Aug. 28, 2007 were priced at 87 and are convertible into 75 million shares at $0.08 each.
The investors received warrants for 75 million shares, exercisable at $0.15 each for eight months and warrants for 37.5 million shares, exercisable for three years at $0.50 each.
The proceeds will be used for a clinical trial research study, sales and marketing efforts, working capital and general corporate purposes.
Connected to the deal, Dobi reduced the conversion price on its series A preferreds to $0.37 from $1.31.
Dobi Medical, based in Mahwah, N.J., is a medical imaging company focused on diagnosing malignant breast cancer.
| Issuer: | Dobi Medical International, Inc.
|
| Issue: | Secured convertible debentures
|
| Amount: | $6 million
|
| Proceeds: | $5.25 million
|
| Maturity: | Aug. 28, 2007
|
| Coupon: | 0%
|
| Price: | 87
|
| Conversion ratio: | Into 75 million shares
|
| Conversion price: | $0.08
|
| Warrants: | For 112.5 million shares
|
| Warrant expiration: | Eight months for 75 million; three years for 37.5 million
|
| Warrant strike price: | $0.15 for 75 million; $0.50 for 37.5 million
|
| Settlement date: | May 1
|
| Stock symbol: | OTCBB: DBMI
|
| Stock price: | $0.08 at close May 1
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
